Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Total Stockholders Equity : د.إ794 Mil (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

What is Gulf Pharmaceutical Industries PSC Total Stockholders Equity?

Gulf Pharmaceutical Industries PSC's Total Stockholders Equity for the quarter that ended in Dec. 2023 was د.إ794 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Gulf Pharmaceutical Industries PSC's Book Value per Share for the quarter that ended in Dec. 2023 was د.إ0.69. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Gulf Pharmaceutical Industries PSC's Debt-to-Equity for the quarter that ended in Dec. 2023 was 1.40.

Gulf Pharmaceutical Industries PSC Total Stockholders Equity Historical Data

The historical data trend for Gulf Pharmaceutical Industries PSC's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gulf Pharmaceutical Industries PSC Total Stockholders Equity Chart

Gulf Pharmaceutical Industries PSC Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

698.60

901.10

956.70

916.50

794.20

Gulf Pharmaceutical Industries PSC Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															916.50	896.90	860.90	818.70	794.20

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Gulf Pharmaceutical Industries PSC's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(794.2	-	0)	/	1155.23
	=	0.69

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Gulf Pharmaceutical Industries PSC's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(254	+	856.6)	/	794.2
	=	1.40

Gulf Pharmaceutical Industries PSC Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Gulf Pharmaceutical Industries PSC's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Airport Road, P.O. Box 997, Digdaga, Ras Al Khaimah, ARE

Website

https://www.julphar.net

Gulf Pharmaceutical Industries PSC is a generic pharmaceutical manufacturer in the Middle East and North Africa. The company manufactures and sells pharmaceuticals and medical compounds, including cosmetics compounds, and drugs. It operates in four segments: Manufacturing, Planet, Investments, and others. It maintains a diverse product portfolio that targets various therapeutic segments including Gastrointestinal Tract (GIT), Respiratory, Pain Management, Wounds & Scars, Anti-infectives, Anemia, Gynecology, Dermatology, Erectile Dysfunction, and Cardiology. The geographical segments are UAE, Other GCC countries, and Other countries.

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Headlines

No Headlines